HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

AI-Aided MRI Provides Cost-Effective Alternative to Painful, Invasive Liver Biopsies

By HospiMedica International staff writers
Posted on 29 Sep 2022
Print article
Image: LiverMultiScan provides three metrics in one single scan that represent amount of fibro-inflammation, fat, and iron in the liver (Photo courtesy of Perspectum)
Image: LiverMultiScan provides three metrics in one single scan that represent amount of fibro-inflammation, fat, and iron in the liver (Photo courtesy of Perspectum)

Patients with autoimmune hepatitis (AIH), a chronic condition, require lifelong treatment with corticosteroids and immunosuppressants. Their clinical management is challenging, with most patients experiencing recurring periods of subdued, followed by flared disease activity - requiring close and continual monitoring using a liver biopsy to adjust drug dose. The expensive, invasive, and imperfect nature of liver biopsy, together with its poor patient acceptance and associated safety risks, especially in children, are driving the urgent need to replace it with cost-effective noninvasive techniques that can accurately monitor disease activity and treatment response in patients with AIH. Now, a new study has shown that an artificial intelligence-enhanced, noninvasive liver health diagnostic tool can be a cost-effective alternative to painful, invasive liver biopsies for monitoring disease activity and treatment response in patients with AIH.

The health economic study performed by Oxford Academic Health Science Network (AHSN, Oxford, UK) showed that Perspectum’s (Oxford, UK) LiverMultiScan could deliver estimated significant cost savings of up to GBP 336,926 for 100 patients over five years if the AI diagnostic tool replaced surveillance liver biopsies in NHS England’s AIH patient care pathways. Over and above reducing healthcare costs, previously published evidence suggests that including LiverMultiScan in the clinical care of patients with AIH could improve clinical decision-making, patient safety, and experience.

LiverMultiScan is a noninvasive MRI scan to aid in the detection of chronic liver disease, delivering a precision image and a detailed, visual report, with quantitative metrics to assess liver tissue characteristics and provide a comprehensive picture of liver health. In a single 15-minute noninvasive MRI procedure, LiverMultiScan provides three clinically significant metrics measuring fibro-inflammation by iron-corrected T1 (cT1), liver fat, measured by proton density fat fraction (PDFF), and correlates of liver iron levels (T2) to help assess the extent of liver disease. LiverMultiScan is the only technology measuring cT1, a proprietary biomarker that measures the level of fibro-inflammation, offering the potential for earlier diagnosis even at the stage when disease progression can still be stopped and reversed, as well as monitoring of disease progression or regression.

“Noninvasive imaging with LiverMultiScan can detect the presence and extent of liver fibro-inflammation in a risk-free manner, resulting in reduced liver biopsy frequency for AIH patients,” noted Mamta Bajre, MBBS, M.Sc. Health Economics, lead author of the study and member of the NHS England’s Oxford AHSN. “Our study demonstrates that integrating LiverMultiScan in AIH patient pathways leads to significant cost savings for the NHS, while reducing hospitalisation and management costs associated with liver biopsy. By eliminating risks and complications associated with liver biopsy, LiverMultiScan helps improve patient outcomes and experience.”

“Although necessary for diagnosis, liver biopsy is not sustainable for long-term monitoring of patients with AIH. Factoring in LiverMultiScan’s economic benefits shown in this independent study with its ability to positively impact clinical management by detecting sub-clinical disease and predicting clinical outcomes, along with feedback from all stakeholders involved in patient care, I can say LiverMultiScan is probably one of the best monitoring tools to support the management of patients with AIH,” said Elizabeth Shumbayawonda, Ph.D., a clinical scientist spearheading the research in AIH and other autoimmune liver diseases at Perspectum.

Related Links:
AHSN 
Perspectum 

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
X-Ray QA Meter
Piranha CT

Print article

Channels

Critical Care

view channel
Image: The new risk assessment tool determines patient-specific risks of developing unfavorable outcomes with heart failure (Photo courtesy of 123RF)

Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients

Heart failure is a serious condition where the heart cannot pump sufficient blood to meet the body's needs, leading to symptoms like fatigue, weakness, and swelling in the legs and feet, and it can ultimately... Read more

Surgical Techniques

view channel
Image: The multi-sensing device can be implanted into blood vessels to help physicians deliver timely treatment (Photo courtesy of IIT)

Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health

Researchers have embarked on a project to develop a multi-sensing device that can be implanted into blood vessels like peripheral veins or arteries to monitor a range of bodily parameters and overall health status.... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more